Oncolytic virus for expression of immune checkpoint modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11779619
APP PUB NO 20200197457A1
SERIAL NO

16725485

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an oncolytic virus comprising nucleotide sequence(s) encoding one or more immune checkpoint modulator(s). It also concerns a pharmaceutical composition comprising effective amount of said oncolytic virus and, eventually, a pharmaceutically acceptable vehicle and its use for treating proliferative diseases such as cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRANSGENE SAFRANCE SHENGELAFENSITEDAN G

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Geist, Michel Brumath, FR 9 203
Marchand, Jean-Baptiste Obernai, FR 17 136
Rittner, Karola Strasbourg, FR 12 132
Silvestre, Nathalie Ergersheim, FR 27 100
Thioudellet, Christine Strasbourg, FR 8 188

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 10, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 10, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 10, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00